- Investing Ideas
- Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
3
0 new
Companies which are more than 50% undervalued based on analyst price target.
3 companies
Selvita
Market Cap: zł480.9m
Provides drug discovery, drug development, and contract testing services in Poland.
SLV
zł26.20
7D
-12.7%
1Y
-21.3%
Ryvu Therapeutics
Market Cap: zł332.0m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł14.36
7D
-6.1%
1Y
-53.5%
Molecure
Market Cap: zł120.5m
A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.
MOC
zł5.85
7D
0%
1Y
-13.1%